- Home
- ANTX vs MPV Comparison
ANTX vs MPV Comparison
Compare ANTX & MPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANTX | MPV |
|---|---|---|
| Founded | 2017 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.9M | 169.4M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | ANTX | MPV |
|---|---|---|
| Price | $5.41 | $17.20 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 218.5K | 22.4K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.71% |
| EPS Growth | ★ 32.56 | N/A |
| EPS | N/A | ★ 1.71 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $9.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $15.05 |
| 52 Week High | $7.19 | $20.58 |
Technical Indicators
Market Signals| Indicator | ANTX | MPV |
|---|---|---|
| Relative Strength Index (RSI) | 53.25 | 42.46 |
| Support Level | $3.91 | $15.88 |
| Resistance Level | $7.05 | $17.43 |
| Average True Range (ATR) | 0.34 | 0.46 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 49.38 | 34.06 |
Price Performance
Historical ComparisonAbout ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
About MPV Barings Participation Investors
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.